4/A: Allstate Corp: CEO Thomas J. Wilson Corrects Stock Option Grant Calculation in Amended SEC Filing
SEC Filing (Form 4/A)
Thomas J. Wilson, Chairman, President & CEO of Allstate Corp, files an amendment to a previous Form 4 to correct the number of stock options granted on February 21, 2024.
Summary
- This is an amendment to a Form 4 filing by Thomas J. Wilson, the Chairman, President, and CEO of Allstate Corp.
- The original filing, submitted on February 23, 2024, contained a calculation error regarding the number of stock options granted to Wilson on February 21, 2024.
- This amended filing, dated March 8, 2024, corrects the error and accurately reports the number of options granted.
- The corrected filing shows that Wilson was granted 119,784 employee stock options with an exercise price of $159.17 on February 21, 2024.
- The options vest in three equal installments on February 21, 2025, February 21, 2026, and February 21, 2027, and expire on February 21, 2034.
Sentiment
Score: 6
Explanation: The document is a routine correction of a previously filed form, indicating a neutral sentiment. It doesn't suggest any positive or negative implications for the company's performance or outlook.
Industry Context
This filing is a routine disclosure related to executive compensation and stock option grants, common in publicly traded companies like Allstate.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are a standard practice among large, publicly traded corporations such as Allstate.
- Companies like State Farm, Progressive, and Berkshire Hathaway (which owns GEICO) also utilize stock options and other equity-based compensation to incentivize their executives.
- The vesting schedules and exercise prices are typically determined by the company's compensation committee and are benchmarked against industry peers to attract and retain top talent.
Stakeholder Impact
- The correction of the stock option grant has a minimal direct impact on stakeholders.
- It ensures transparency and accuracy in reporting executive compensation, which is important for shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/21/2024 | Date of original transaction (stock option grant) |
| 02/21/2025 | First vesting date for one-third of the options |
| 02/21/2026 | Second vesting date for one-third of the options |
| 02/21/2027 | Third vesting date for one-third of the options |
| 02/21/2034 | Expiration date of the stock options |
| 02/23/2024 | Date of original Form 4 filing with incorrect information |
| 03/08/2024 | Date of amended Form 4/A filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.